Scholar Rock Holding Corp. (SRRK)
49.96
-0.04
(-0.08%)
USD |
NASDAQ |
Apr 17, 16:00
49.75
-0.21
(-0.42%)
After-Hours: 20:00
Scholar Rock SG&A Expense (Quarterly) : 45.02M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 41.45M |
| Stoke Therapeutics, Inc. | 21.15M |
| Biogen, Inc. | 682.50M |
| Eli Lilly & Co. | 3.132B |
| Apellis Pharmaceuticals, Inc. | 147.10M |